Fractured talar beaks

Williams, D G; Gandhi, Monika; Barrington, N.A.; Smith, Tom W.

doi:10.1016/s0958-2592(97)90044-4

Cited by 1 publication

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients who use cyclophosphamide for a prolonged period are at increased risk of developing malignancies in bone marrow, lymph nodes and especially bladder (Talar-Williams et al, 1996). The risk of bladder cancer is greater for patients who receive cyclophosphamide orally.…”

Section: Adverse Effects Of Cyclophosphamidementioning

confidence: 99%

“…Chronic use of cyclophosphamide may also cause bleeding from the bladder, the severity ranging from microscopic haematuria to haemorrhagic cystitis, which can be lifethreatening (Talar-Williams et al, 1996). The IV administration of cyclophosphamide combined with the protective organosulphur compound MESNA may reduce bladder toxicity (http://www.accessdata.fda.gov/drugsatfda_docs/label/ 2012/012141s089lbl.pdf accessed July 2013).…”

Section: Adverse Effects Of Cyclophosphamidementioning

confidence: 99%

See 1 more Smart Citation

Systemic use of non‐biologic agents in orofacial diseases: other immunomodulatory agents

Georgakopoulou

Scully²

2013

Oral Diseases

View full text Add to dashboard Cite

Systemic non-biologic agents have long been in clinical use in medicine -often with considerable efficacy, albeit with some adverse effects -as with all medications. With the advent of biologic agents, all of which currently are restricted to systemic use, there is a growing need to ensure which agents have the better therapeutic ratio. The non-biologic agents (NBAs) include a range of agents, most importantly the corticosteroids (steroids). Previous articles by us in this series have discussed systemic use of corticosteroids and purine synthesis inhibitors; the other immunomodulating agents (calcineurin inhibitors, thalidomide, dapsone, colchicine and cyclophosphamide) are reviewed in this final article.

show abstract

Section: Adverse Effects Of Cyclophosphamidementioning

confidence: 99%

Section: Adverse Effects Of Cyclophosphamidementioning

confidence: 99%